ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria
Authors
Keywords
-
Journal
Nano-Micro Letters
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-20
DOI
10.1007/s40820-020-0410-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AMPK: a therapeutic target in RA?
- (2019) Jessica McHugh Nature Reviews Rheumatology
- Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy
- (2019) Jingchao Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Suppression of Lipogenesis via Reactive Oxygen Species–AMPK Signaling for Treating Malignant and Proliferative Diseases
- (2018) Xing-Xing Fan et al. ANTIOXIDANTS & REDOX SIGNALING
- Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling
- (2018) Ying Wang et al. JOURNAL OF CELL BIOLOGY
- Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly
- (2018) Elizabeth C Hinchy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the extracellular matrix for delivery of bioactive molecules to sites of arthritis
- (2018) Christopher Schultz BRITISH JOURNAL OF PHARMACOLOGY
- Cell metabolism as a potentially targetable pathway in RA
- (2018) Trudy McGarry et al. Nature Reviews Rheumatology
- AMPK: guardian of metabolism and mitochondrial homeostasis
- (2017) Sébastien Herzig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
- (2015) Jonathan T. Sockolosky et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanomedicine delivers promising treatments for rheumatoid arthritis
- (2015) Leena Kumari Prasad et al. Nanomedicine
- Leukocyte-specific protein 1 regulates T-cell migration in rheumatoid arthritis
- (2015) Seong-Hye Hwang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
- (2015) Raphael Sanches Peres et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell migration in rheumatoid arthritis
- (2015) Mario Mellado Frontiers in Immunology
- Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples
- (2013) Bernard Combe et al. ANNALS OF THE RHEUMATIC DISEASES
- Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritis
- (2013) E. Feist et al. RHEUMATOLOGY
- Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
- (2013) Maja Bulatović Ćalasan et al. ARTHRITIS RESEARCH & THERAPY
- A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
- (2011) Xu Wang et al. ACS Nano
- Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis
- (2010) Zhenlin Hu et al. ARTHRITIS AND RHEUMATISM
- Innate Immunity and Rheumatoid Arthritis
- (2010) Angelica Gierut et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- The development of novel therapies for rheumatoid arthritis
- (2008) Ling-dong Quan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More